CareDx Stock Forecast
NASDAQ: CDNAHealth CareMedical SpecialitiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CDNA analyst consensus
Consensus (8 analysts)
buy
Avg. price target
$94.43+34.90%
- Strong buy 1
- Buy 5
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 8 Wall Street analysts covering CareDx (2026-11-22), 6 rate the stock a buy or strong buy, 2 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $94.43, with a high estimate of $100.00 and a low estimate of $90.00. The average target implies upside of 34.9% from the current price of $70.00.
The spread between the highest and lowest targets is 11.1%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for CDNA.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 13% |
| Buy | 5 | 63% |
| Hold | 2 | 25% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-11-22.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $90.00 | +28.57% |
| Average target | $94.43 | +34.90% |
| High target | $100.00 | +42.86% |